What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
His primary areas of investigation include Internal medicine, Surgery, Gastroenterology, Chemotherapy and Immunology.
His work deals with themes such as Oncology and Pathology, which intersect with Internal medicine.
Sante Tura has included themes like Thalidomide and Multiple myeloma in his Surgery study.
His Gastroenterology research focuses on subjects like Survival analysis, which are linked to Alpha interferon.
The Chemotherapy study combines topics in areas such as Survival rate and Regimen.
Sante Tura has researched Immunology in several fields, including Cancer research and Stem cell.
His most cited work include:
- Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study (1065 citations)
- Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. (508 citations)
- Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6 (358 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Immunology, Surgery, Gastroenterology and Chemotherapy.
As part of the same scientific family, Sante Tura usually focuses on Internal medicine, concentrating on Oncology and intersecting with Hematology.
As a member of one scientific family, Sante Tura mostly works in the field of Immunology, focusing on Haematopoiesis and, on occasion, Progenitor cell and CD34.
He regularly ties together related areas like Disease in his Surgery studies.
His research integrates issues of Cytarabine, Mitoxantrone and Toxicity in his study of Gastroenterology.
His studies in Chemotherapy integrate themes in fields like Survival rate, Radiation therapy and Prednisone.
He most often published in these fields:
- Internal medicine (43.96%)
- Immunology (30.38%)
- Surgery (23.58%)
What were the highlights of his more recent work (between 2007-2020)?
- Internal medicine (43.96%)
- Surgery (23.58%)
- Immunology (30.38%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Surgery, Immunology, Chemotherapy and Lymphoma.
His Internal medicine research incorporates themes from Gastroenterology and Oncology.
The study of Surgery is intertwined with the study of Splenectomy in a number of ways.
His Immunology research is multidisciplinary, incorporating elements of Cancer research and Position paper.
His research in Chemotherapy intersects with topics in Myeloid and Regimen.
His Multiple myeloma study deals with Bone marrow intersecting with Monoclonal, Transplantation and Ex vivo.
Between 2007 and 2020, his most popular works were:
- Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders (152 citations)
- Consensus conference on the management of tumor lysis syndrome. (103 citations)
- Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. (96 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
His scientific interests lie mostly in Internal medicine, Surgery, Gastroenterology, Chemotherapy and Bone marrow.
His work focuses on many connections between Surgery and other disciplines, such as Incidence, that overlap with his field of interest in Platelet sequestration, Platelet, Splenectomy, Corticosteroid therapy and Autoimmune thrombocytopenia.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Waldenstrom macroglobulinemia, Lymphoproliferative disorders, Refractory, Cyclophosphamide and Immunopathology.
His Chemotherapy research integrates issues from Myeloid and Macroglobulinemia.
The concepts of his Bone marrow study are interwoven with issues in Biopsy, Malignancy and Multiple myeloma.
His study in Lymphoma is interdisciplinary in nature, drawing from both Radiation therapy and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
